Yoon Kim, DO
Allergy · Greensboro, NCNPI 1134407869
Payments from drug & device makers
Across 610 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$1K
- Amgen$1K
- GSK$949
- Takeda Pharmaceuticals U.S.A., Inc.$624
- plus $5K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 82 | $2,894 |
| Regeneron Healthcare Solutions, Inc. | 82 | $1,760 |
| Sanofi | 73 | $1,460 |
| Amgen(2 entities) | 57 | $1,222 |
| GSK | 56 | $949 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $624 |
| Kaleo, Inc. | 27 | $529 |
| Novartis | 21 | $485 |
| Pfizer | 19 | $472 |
| AbbVie | 13 | $401 |
| CSL Behring | 16 | $369 |
| Biocryst US Sales Co., LLC | 14 | $311 |
| Teva Pharmaceuticals USA, Inc. | 15 | $253 |
| Genentech USA, Inc. | 5 | $238 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $217 |
| Optinose US, Inc. | 7 | $216 |
| Regeneron | 5 | $162 |
| Aytu Biopharma, Inc. | 9 | $152 |
| Covis Pharma GmbH | 11 | $150 |
| Boehringer Ingelheim | 7 | $124 |
| Grifols USA, LLC | 6 | $118 |
| Hikma Pharmaceuticals USA | 6 | $105 |
| Mylan Specialty L.p. | 4 | $98 |
| Galderma Laboratories, L.p. | 5 | $88 |
| LEO Pharma Inc. | 4 | $68 |
| Ionis Pharmaceuticals, Inc. | 3 | $64 |
| USWM, LLC | 3 | $54 |
| Shire North American Group Inc | 3 | $47 |
| Lilly USA, LLC | 2 | $47 |
| Organon | 2 | $47 |
| Alk-abello, Inc | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Hospira, Inc. | 2 | $34 |
| Incyte Corporation | 1 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Eyevance Pharmaceuticals LLC | 1 | $18 |
| Viatris Specialty LLC | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
| Biocryst Pharmaceuticals, Inc. | 1 | $14 |
How this compares
Too few allergy providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Greensboro
- Robert van WinkleGreensboro$5K
- Meg WhelanGreensboro$4K
- Ranjan SharmaGreensboro$2K
- Katherine OberhelmanGreensboro$365
- Eveline WuChapel Hill$1.1M
- Charles HumphriesCharlotte$58K
- Thomas OfferleCharlotte$781
- Hunter SmithChapel Hill$242
- Elizabeth IsbisterHarbinger$15
- Mildred KwanChapel Hill$11
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.